Association of pregnancy complications and choice of immunosuppressant in liver transplant patients.
| Autor: | Casele HL; University of Pittsburgh Health Sciences Center, Department of Obstetrics, Gynecology and Reproductive Sciences, Pennsylvania 15213, USA., Laifer SA |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Transplantation [Transplantation] 1998 Feb 27; Vol. 65 (4), pp. 581-3. |
| DOI: | 10.1097/00007890-199802270-00023 |
| Abstrakt: | Background: The purpose of this study was to identify factors associated with antenatal complications for an ongoing series of pregnant women who have undergone orthotopic liver transplantation. Methods: We reviewed Magee-Womens Hospital records from 14 pregnancies in 13 women in whom a liver had been transplanted before pregnancy. We collected and analyzed data regarding the primary liver disease, allograft status, liver function at conception and during pregnancy, immunosuppressive medications, associated medical conditions, time from transplant to conception, cytomegalovirus serostatus, and maternal and fetal outcome. Results: Seven patients had evidence of renal dysfunction (creatinine, 1.3-2.0 mg/dl), five of whom also were hypertensive at their first prenatal visit. The complications of preeclampsia, worsening hypertension, and small for gestational age occurred only in women with renal dysfunction at conception. Renal dysfunction was more often associated with cyclosporine than tacrolimus use. Conclusions: Renal dysfunction is the primary determinant of adverse pregnancy outcome in liver transplant recipients. Immunosuppression with cyclosporine during pregnancy was more often associated with antenatal complications than with the use of tacrolimus. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|